NCT02271997View on ClinicalTrials.gov

Optimizing Iron Suppletion After Roux-en-Y Gastric Bypass

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 4, 2014

Primary Completion Date

June 6, 2017

Study Completion Date

June 6, 2017

Conditions
Iron Deficiency
Interventions
DRUG

Ferrous fumarate

treatment with ferrous fumarate during 1 year and 6,12,26 and 52 weeks after starting treatment iron spectrum will be measured

DRUG

Ferrous gluconate

treatment with ferrous gluconate during 1 year and 6,12,26 and 52 weeks after starting treatment iron spectrum will be measured

DRUG

Iron(III)carboxymaltose

treatment with Iron(III)carboxymaltose and 6,12,26 and 52 weeks after starting treatment iron spectrum will be measured

Trial Locations (3)

1061 AE

OLVG West/ Sint Lucas Andreas Ziekenhuis, Amsterdam

6800WC

Rijnstate hospital, Arnhem

Unknown

Rose Kruis Ziekenhuis, Beverwijk

All Listed Sponsors
lead

Rijnstate Hospital

OTHER

NCT02271997 - Optimizing Iron Suppletion After Roux-en-Y Gastric Bypass | Biotech Hunter | Biotech Hunter